91 results about "Levofloxacin" patented technology

The invention relates to a preparation method and application of a composite piezoelectric catalytic material NaNbO3-coated BiFeO3 for rapidly degrading antibiotics, NaNbO3 is flaky crystal grains with [001] crystallographic orientation prepared by a two-step molten salt method, and BiFeO3 is micro-nano particles prepared by a coprecipitation method. Composite micro-nano BiFeO3 powder and [001] oriented NaNbO3 flaky grains form a heterojunction, conversion of mechanical energy and electric energy of the material is achieved under the ultrasonic vibration condition, inductive charges are generated on the surface of the material, and photon-generated carriers move reversely under driving of a built-in electric field. According to the invention, the piezoelectric catalytic degradation capability of the BiFeO3 and NaNbO3 composite piezoelectric catalytic materials with different proportions on four antibiotics, namely oxytetracycline, levofloxacin, carbamazepine and paracetamol in different time periods is researched. When the mass ratio of the BiFeO3 to the NaNbO3 composite material is 1: 3, the oxytetracycline degradation rate within 30 min can reach 78.2%, the oxytetracycline degradation rate within 120 min can reach 91.8%, and the piezoelectric electro-catalysis characteristic is rapid and efficient. The method disclosed by the invention has important significance in developing a high-efficiency piezoelectric catalyst for degrading antibiotics.

The invention discloses a surface defect and oxygen doping co-modified pore-rich g-C3N4 nano material as well as preparation and application thereof. The preparation method comprises the following steps: mixing a white viscous melamine-cyanuric acid suspension with an oxalic acid solution to obtain a melamine-cyanuric acid-oxalic acid suspension solution, carrying out hydrothermal treatment to obtain a hydrogen bond connected self-assembled supramolecular aggregate, and finally carrying out thermal polycondensation on the self-assembled supramolecular aggregate and formaldehyde to obtain the surface defect and oxygen doping co-modified porous g-C3N4. The surface defect and oxygen doping co-modified g-C3N4 nano material with different morphologies and physicochemical properties is obtained. The preparation method is simple in process flow, efficient, low in cost and suitable for large-scale production, and the synthesis process meets the green chemical requirement; the obtained nano material has a higher specific surface area and more active sites, and has higher catalytic reaction and adsorption performance on organic pollutants, namely levofloxacin, ciprofloxacin and tetracycline hydrochloride, in a water body.

The invention relates to a method for detecting six second-line antituberculous drugs by high performance liquid chromatography. The method comprises the following steps: providing an internal standard stock solution and a standard stock solution of six second-line antituberculosis drugs; preparing an internal standard working solution and a standard curve working solution by utilizing the diluent; preparing a solution of a product to be detected by using the Tianlongitudinal sample extraction liquid TZ-002; a liquid chromatograph is used for detection, and the conditions are as follows: a mobile phase A is a Tianlongitudinal sample releasing agent TZ-D004; a mobile phase B is acetonitrile; a mobile phase C is water; and gradient elution. According to the method, the plasma concentration of the second-line antituberculous drug taken by a tuberculosis patient is measured by applying the reversed-phase high-performance liquid chromatography, the cost is relatively low, the analysis time is short, the sensitivity is high, and the accuracy is high. The kit can be used for simultaneously detecting the blood concentration of six second-line antituberculosis drugs such as isopropylthioamide, levofloxacin, linezolid, moxifloxacin, deramanib and bedaquiline in human serum, and is expected to provide a more reliable basis for clinicians to adjust the dosage of the antituberculosis drugs.

This invention belongs to the field of environmental chemical catalytic water treatment technology and discloses a method for preparing a Cu2O / black phosphorus catalyst for removing antibiotics from water. Using Cu2O and black phosphorus (BP) as precursor reactants, a series of Cu2O / BP composite photocatalysts were prepared. The BP catalyst was prepared by a simple hydrothermal method. Then, Cu(NO3)2·3H2O and BP were calcined in varying proportions to form the composite Cu2O / BP photocatalysts. Analysis revealed that the Cu2O was loaded onto the BP layer, forming a composite structure. The prepared catalysts were used to degrade levofloxacin hydrochloride under visible light, and the catalytic activity of the composite photocatalysts was evaluated. Results showed that among the photocatalysts with varying Cu2O / BP loadings, 3% and 4% Cu2O / BP exhibited the best photocatalytic degradation performance, achieving a degradation rate of 89% in 3 hours, 2.83 times that of pure BP. This demonstrates the successful preparation of highly efficient composite catalysts.

The invention discloses a blue fluorescent carbon dot as well as a preparation method and application thereof, and belongs to the technical field of drug monitoring. The carbon dot is a boron-nitrogen co-doped carbon dot, a carbon source is citric acid, a nitrogen source is p-phenylenediamine, and a dopant is boric acid; wherein the mass ratio of the citric acid to the boric acid to the p-phenylenediamine is (10-13): (12-15): (11-14). The preparation method comprises the following steps: mixing citric acid, boric acid and p-phenylenediamine, adding ethanol, carrying out ultrasonic treatment, heating at 150-200 DEG C for 20-60 minutes, cooling to room temperature, and purifying and drying supernate to obtain the blue fluorescent carbon dots. The blue fluorescent carbon dot provided by the invention is simple in preparation method, easily available in raw materials and suitable for industrial production, and the prepared fluorescent carbon dot can be used for drug monitoring of vancomycin and is also suitable for detecting ofloxacin and / or levofloxacin in food.

The present invention relates to an ophthalmic composition in the form of an aqueous solution containing levofloxacin or salt or derivative thereof and ketorolac or salt or derivative. The present invention relates to an ophthalmic composition in the form of an aqueous solution containing levofloxacin or salt or derivative thereof and ketorolac or salt or derivative thereof, for use in a method for the treatment of conjunctivitis and for the prevention or treatment of inflammation or prevention of infection after cataract surgery in a subject, according to a dosage regimen that improves patient compliance and tolerability and enables the prevention and treatment of intermediate / antibiotic-resistant infections.

According to the method, melamine and urea are used as carbon and nitrogen sources, hollow tubular phosphorus-doped carbon nitride is constructed by adopting a sodium polyphosphate-assisted hydrothermal-thermal polymerization method, molybdenum disulfide is loaded on the surface of P-TCN in a hydrothermal in-situ growth mode, and the hollow tubular phosphorus-doped heterojunction photocatalyst is obtained. The hollow tubular phosphorus-doped heterojunction photocatalyst P-TCN / MoS2 is prepared; the catalyst disclosed by the invention shows excellent degradation performance on ciprofloxacin, levofloxacin, rhodamine B and methylene blue under an illumination condition. The catalyst disclosed by the invention is simple in preparation method, low in cost and easily available in raw materials, and has a wide application prospect in the field of photocatalytic treatment of antibiotic and dye wastewater.

The invention discloses a Co3O4-Cu2-xS composite photo-thermal catalyst as well as a preparation method and application thereof. The composite photo-thermal catalyst is prepared by taking a surfactant as a bridge and compounding Co3O4 and Cu2-xS. The composite photo-thermal catalyst has a reduced band gap width, can effectively promote migration and separation of photon-generated carriers, enhances the absorption efficiency of visible light-near infrared light, and shows excellent photo-thermal conversion performance. The composite photo-thermal catalyst can be used for constructing a Co3O4-Cu2-xS + PMS + NIR catalytic system, and peroxymonosulfate is activated under the irradiation of near-infrared light so as to degrade antibiotics in water. Experiments prove that the Co3O4-Cu2-xS + PMS + NIR system disclosed by the invention can achieve the degradation rate of 99% on levofloxacin within 20 minutes, and the generation efficiency of active species is remarkably improved through the synergistic effect of a photothermal effect and interface activation. The catalyst has broad-spectrum degradation activity on various antibiotics, keeps efficient and stable catalytic performance in a wide pH range, and shows excellent ion interference resistance and adaptability to various water bodies.

The utility model discloses a levofloxacin hydrochloride tablet preparation raw material quick mixing device, including frame, the frame top is provided with removal subassembly, the frame inside is provided with mixing box through removal subassembly, the both sides of mixing box are provided with guide component, and guide component is connected with the frame, the mixing box top is provided with drive assembly, the mixing box is provided with the pivot through drive assembly in the inside, the pivot is rotatably connected with mixing box, the pivot surface fixed mounting has the stirring rod. This kind of stirring and shaking combined mode can make raw materials flow and mix in multiple dimensions, can effectively avoid the situation that raw materials are not mixed sufficiently in local area, significantly improve the uniformity and effect of mixing, apply force to raw materials from different directions, speed up the mutual blending and diffusion between raw materials, can reach the ideal mixing state in shorter time, thereby improve the overall mixing efficiency, save production time.

The invention belongs to the technical field of environmental functional materials, and relates to a heterojunction photocatalyst as well as a preparation method and application thereof. The heterojunction photocatalyst is of a Z-type energy band structure and comprises beam-shaped h-BN and Ag3PO4 nano-particles loaded on the beam-shaped h-BN, and the particle size of the Ag3PO4 nano-particles ranges from 1 nm to 20 nm. According to the heterojunction photocatalyst, the initial degradation rate of levofloxacin hydrochloride in visible light within 60 min is larger than or equal to 88%, and the degradation rate is kept to be 80% or above after four times of circulation.

The application belongs to the technical field of electroluminescence, and particularly relates to a preparation method of a high-entropy oxide material and application of the high-entropy oxide material in electrochemiluminescence detection of levofloxacin. The high-entropy oxide material is a kind of five-element high-entropy oxide HEO-800 material with simple raw materials, convenient synthesis, excellent electrochemiluminescence performance, which is synthesized by taking metal nitrate of Fe, Co, Cu, Zn and Ni as raw materials, and taking Na2CO3 and NaOH as raw materials. The HEO-800 material has excellent conductivity and chemical stability, and a multi-electron reaction potential accelerates the conversion of dissolved oxygen into reactive oxygen species (ROS), enhances the electroluminescence intensity, and based on the quenching effect of LVX, a method for detecting LVX by using a luminol / HEO-800 system is established. By fitting the change of ECL intensity with the concentration of LVX, a linear calibration curve is obtained, the correlation coefficient is 0.993, and the detection limit is 1.02*10 ‑5 μM (S / N=3). The material has good sensitivity, stability and reproducibility for electrochemiluminescence detection of LVX, and provides a new scheme for designing a new electrocatalyst for testing LVX.

The application discloses a flagellum inhibiting peptide of pseudomonas aeruginosa and a preparation method and application thereof, and the sequence of the flagellum inhibiting peptide is Lys-Ile-Gly-Leu-Phe-Arg-Trp-Arg. The synthetic inhibiting peptide has a time-dependent self-assembly ability, can gradually evolve from scattered granular into filamentous structure, and finally forms a stable net-like morphology. The synthetic inhibiting peptide can significantly inhibit the flagellum motility of PAO1 and other strains of pseudomonas aeruginosa, and has synergistic antibacterial activity when combined with allicin, ciprofloxacin, meropenem, levofloxacin, polymyxin B and the like. Moreover, the synthetic inhibiting peptide has obvious bacteriostatic and healing-promoting effects on burn wound infection.

The invention discloses a medical dressing capable of absorbing moisture and releasing sweat and a preparation method of the medical dressing, and relates to the technical field of medical dressings, the medical dressing comprises a polyurethane copolyester nanofiber membrane, and the preparation method of the polyurethane copolyester nanofiber membrane comprises the following steps: pouring non-isocyanate polyurethane copolyester, levofloxacin and polyacrylonitrile into hexafluoroisopropanol, and stirring uniformly; carrying out electrostatic spinning; and spin-coating a chitosan-gelatin-glycerol mixed solution, and spin-coating a spermidine cross-linking agent to obtain the polyurethane copolyester nanofiber membrane. By introducing the polyglycolic acid-based non-isocyanate polyurethane copolyester and the levofloxacin, the levofloxacin is uniformly dispersed and embedded into a fiber network, so that uniform dispersion and controllable release of an antibacterial drug are realized, growth and reproduction of bacteria at a wound are effectively inhibited, and the problems of wound infection and slow healing are solved; the healing speed is increased; and the complication risk is reduced.

The invention provides a characteristic gene combination for predicting the drug sensitive phenotype of stenotrophomonas maltophilia to levofloxacin and compound sulfamethoxamine. The characteristic gene combination for predicting the drug sensitive phenotype of stenotrophomonas maltophilia to levofloxacin comprises parC: 254 (G-gt; a), ParC: 259 (A-gt; c), ParC: 260 (G-gt; t), gyrA: 248 (A-gt; t), smT: 12 (G-gt; t) and the like; the characteristic genes of the drug sensitivity phenotype of the compound sulfamethoxazole include sul1, sul2, Gsh2: 1076 (C-gt; g), smT: 12 (G-gt; t), cysJ: 445 (C-gt; a), 14242002, etc. According to the characteristic gene combination obtained through screening, the drug sensitivity phenotype prediction result of stenotrophomonas maltophilia levofloxacin and compound sulfamethoxamine is greatly shortened.

This invention discloses a method and application for preparing metal-doped composite catalysts based on ZIF-67, relating to the field of wastewater treatment technology. This invention constructs a multi-component synergistic system through the coordination of functional groups on the surface of biochar with ZIF-67 and the electronic coupling effect between rare earth metals and Co. Compared with traditional pure chemical support synthesis methods, this reduces costs and improves environmental compatibility. The metal-doped composite catalyst prepared by this invention is a novel heterogeneous catalyst. Through the electrostatic interaction between the biochar support and Co ions, and the metal-metal bonds formed between La / Ce and Co, it significantly enhances the stability of Co ions, effectively avoiding secondary pollution. The metal-doped composite catalyst prepared by this invention can efficiently activate persulfate to generate reactive oxygen species and synergistically remove multiple pollutants from complex water bodies containing sulfamethoxazole, tetracycline, levofloxacin, and other antibiotics such as methylene blue.

The application relates to the technical field of compound preparation, and discloses a synthesis method of fosfomycin intermediate levofosfoxacin salt, which comprises the following steps: taking propynol as raw material, performing esterification reaction, adding Pt / C, Cu (II) EDTA and hydrogen into the obtained reaction solution to prepare a cis-propenyl dichloro oxygen phosphorus solution, adjusting the pH of the reaction solution by using ammonia gas after hydrolysis, and performing salt reaction and epoxidation by using R- (+) -alpha-phenylethylamine to obtain the product after post-treatment. The propynol is not hydrolyzed after esterification, so that the impurity propadienyl phosphate is reduced; the later hydrogenation can obtain higher-purity cis-propenyl phosphate; the step of hydrolysis after esterification is reduced, a large amount of water does not need to be distilled and concentrated, and energy consumption is reduced; the reaction temperature and hydrogen pressure in the hydrogenation step are both low, and the reaction safety is high; R- (+) -alpha-phenylethylamine is used in the epoxidation stage, so that the splitting operation is not needed, and the process is simplified; the solvents can be recycled and reused, and the method is environment-friendly.

The invention provides a method for improving the purity of a levofloxacin product, which comprises the following steps: carrying out condensation reaction on levofloxacin carboxylic acid, dimethyl sulfoxide and N-methyl piperazine, adding water into the obtained concentrate, adding a specific acidic reagent to adjust the pH value of the system to 1.0-4.5, heating to dissolve, cooling to separate out impurities, filtering, adding trichloromethane into the filtrate, extracting under the condition that the pH value is 7.0-7.5, and filtering to obtain the levofloxacin product. And collecting an organic phase, concentrating, adding ethanol, and crystallizing to obtain a high-purity levofloxacin product. According to the method, by limiting the raw material ratio, the process conditions and the specific acid reagent, generation of an isomeride impurity I is reduced from the reaction source, efficient separation of the impurity I and the levofloxacin is achieved, the content of the isomeride impurity I in the levofloxacin product is remarkably reduced, and the purity of the levofloxacin product is improved. Meanwhile, other insoluble impurities under the acidic condition are removed through filtration, so that a high-purity product with the purity of 99.86% or above is obtained. The whole impurity removal process is simple, efficient, safe, environment-friendly and especially suitable for large-scale industrial production.

A method for degrading levofloxacin in wastewater based on a visible light-driven CMP (Chemical Molecular Polymer) photocatalytic system is disclosed. This invention aims to address the problems of most existing photocatalysts being only responsive to ultraviolet light, having limited solar energy utilization efficiency, being highly susceptible to the influence of wastewater turbidity and color, and exhibiting low degradation efficiency for norfloxacin. The method comprises: 1. Synthesizing a conjugated microporous polymer; 2. Performing photocatalytic degradation under visible light irradiation. This invention aims to achieve efficient solar energy utilization by utilizing the excellent photogenerated charge generation and transport efficiency of conjugated microporous polymers for the efficient degradation of levofloxacin. This provides a mild, efficient, and environmentally friendly green method for degrading the novel pollutant levofloxacin, offering a new option for treating complex industrial wastewater.

The invention relates to a pH responsive hydrogel drug delivery system for corneal neovascularization treatment, which is a composite hydrogel LEV-DG-HPMC formed by forming LEV-DG nano-micelles from drugs levofloxacin and dipotassium glycyrrhizinate by a film dispersion method, then heating and self-assembling to form LEV-DG hydrogel, and introducing hydroxypropyl methylcellulose as a tackifier. The drug delivery system disclosed by the invention has unique pH response characteristics, can accurately identify the alkali burn microenvironment and control the release of drugs, and obviously prolongs the cornea residence time. Through the synergistic effect of DG and LEV, the vicious circle of infection-inflammation-neovascularization is effectively blocked. Experiments show that the system can significantly reduce the corneal neovascularization area and accelerate epithelium repair, has good biocompatibility and treatment effect, and provides a new solution for treatment of corneal alkali burn.

This invention discloses a compound ointment for protecting the nasal mucosa and repairing skin damage, and its preparation method, belonging to the field of pharmaceutical technology. The compound ointment is formulated with Sophora japonica fruit extract, erythromycin ointment, vitamin B6, levofloxacin hydrochloride tablets, loratadine tablets, fluticasone propionate nasal spray, sesame oil, and honey in specific weight proportions. The components work synergistically, providing protection for the nasal mucosa, treatment of rhinitis, reduction of cold air and external pollutant intrusion, and prevention of colds. It can also treat hemorrhoids, scars, eczema, and other skin damage, achieving "one medicine for multiple uses." This compound ointment has a stable dosage form, is convenient to use, has high utilization rate, high safety, and no obvious side effects, making it suitable for various populations and possessing good industrialization prospects.

The invention discloses a pharmaceutical composition and a nano preparation, a preparation method and application thereof, and relates to the technical field of biomedicine.The pharmaceutical composition comprises gallium salt and levofloxacin, the molar ratio of the gallium salt to the levofloxacin is 4: 1-300: 1, and the nano preparation comprises a polyphenol compound and the pharmaceutical composition. The gallium salt and the polyphenol compound are coordinated and complexed to form a network structure, and levofloxacin is loaded; the preparation method is a fractional step method or a one-pot synthesis method. The medicine for treating pseudomonas aeruginosa infection, which is prepared from the nano preparation, is delivered to the lung in an atomization administration manner; the invention has the following beneficial effects: the synergistic antibacterial activity is significantly enhanced; the drug stability and bioavailability are improved; and a stable platform is provided for subsequent surface targeted modification.

The invention discloses catalytic sludge biochar for strengthening iron-nitrogen anchoring through spatial constraint as well as a preparation method and application of the catalytic sludge biochar, and belongs to the technical field of organic solid waste recycling. The preparation method comprises the following steps: mixing an iron source, sludge and urea according to a certain mass ratio, adjusting the water content to 7-25%, and extruding, granulating and molding into granules with compact structures in a specific manner; and then pyrolyzing in an inert atmosphere to prepare the catalytic sludge biochar. The preparation method provided by the invention can effectively inhibit the volatilization loss of nitrogen element in the pyrolysis process and promote the reaction of iron and nitrogen, so that a rich FexN active structure is efficiently and directionally generated under the extremely low level that the use amount of urea is only 1-12% of the mass of sludge. The catalytic sludge biochar disclosed by the invention is excellent in performance, and the degradation removal rate of levofloxacin is as high as 98.94%. The method is simple in process and low in cost, and a brand new technical scheme is provided for high-value resource utilization of the sludge and efficient and economic treatment of the antibiotic wastewater difficult to degrade.

The present invention belongs to the technical field of catalysts for sewage treatment, and in particular to a CoAl-LDO / MoS2 heterojunction ozone catalyst and its preparation method and application. The preparation of the present invention comprises the following steps: obtaining a MoS2 precursor; dispersing the MoS2 precursor, a cobalt salt, an aluminum salt and a precipitant into deionized water for ultrasonic dispersion and stirring, and performing a hydrothermal reaction; collecting the product by centrifugation, washing, drying and calcining to obtain a CoAl-LDO / MoS2 heterojunction ozone catalyst. The preparation method of the CoAl-LDO / MoS2 heterojunction ozone catalyst provided by the present invention has a simple process and mild reaction conditions; the obtained ozone catalyst is applied to the degradation of antibiotics, and the effect is good. The ozone catalyst of the present invention has a large specific surface area, high active site accessibility, oxygen vacancies that are not easily deactivated and good stability, and has a good degradation effect on tetracycline hydrochloride, levofloxacin, etc.

The invention provides a temperature-sensitive hydrogel for resisting bacteria and promoting repair and a preparation method thereof, the temperature-sensitive hydrogel comprises PEG-NB, a matrix metalloproteinase degradable peptide cross-linking agent, gelatin, indocyanine green and levofloxacin, and the temperature-sensitive hydrogel is prepared by photo-crosslinking. According to the temperature-sensitive hydrogel provided by the invention, the structure and the performance of the hydrogel are optimized through the synergistic effect of the gelatin and the PEG-NB, and the mechanical strength, the biocompatibility, the degradability and the like of the hydrogel are remarkably improved; meanwhile, the photo-thermal antibacterial function of the photo-thermal agent indocyanine green and the chemical antibacterial function of levofloxacin are integrated, and near-infrared light irradiation is combined, so that the antibacterial and skin repair promoting effects of the hydrogel are synergistically improved.

The invention provides enterococcus faecalis bacteriophage vBEfaS-1017 and application thereof, the enterococcus faecalis bacteriophage vBEfaS-1017 is preserved in China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC NO.46182, and the preservation time is September 6, 2024. The bacteriophage vBEfaS-1017 is high in specificity, short in incubation period and ultrahigh in stability, and has activity under the conditions of extreme pH, high temperature and ultraviolet radiation; by evaluating the in-vitro bactericidal efficacy of the bacteriophage vBEfaS-1017, it is determined that the bacteriophage vBEfaS-1017 can effectively remove a biological membrane formed by host bacteria Ef 10-17, the removal rate is as high as 90%, and the bacteriophage vBEfaS-1017 is expected to become a scavenger for solving the biological membrane. Further experiments prove that the bacteriophage vBEfaS-1017 has in-vivo and in-vitro safety. Through combined use of the bacteriophage and different antibiotics, it is found that combined use of the bacteriophage vBEfaS-1017 and the antibiotic levofloxacin can effectively treat bacteremia of mice, the treatment time after infection can be prolonged by using the bacteriophage in advance, and the bacteriophage has a good application prospect in the aspect of preventing and treating enterococcus faecalis.

A triple antibiotic nanofiber scaffold for wound dressings, consisting of: (a) a polymer blend of polyacrylonitrile and pullulan in a weight ratio of about 10:1; (b) one or more fluoroquinolone active ingredients selected from levofloxacin, ciprofloxacin and ofloxacin in different concentrations; wherein the polymer-drug solution is electrospun using a voltage of about 15 kV and a flow rate of about 5 ml / h to form uniform nanofiber mats on a collector covered with aluminum foil, and where the nanofibers are configured to provide structural integrity, drug loading capacity, and potential wound healing properties.

The invention discloses a method for detecting dimethylamine in levofloxacin, which comprises the following steps: weighing levofloxacin, adding a diluent for dissolving and diluting, and taking filtrate to obtain a test solution; taking a dimethylamine hydrochloride reference substance, and adding a diluent for dissolving and diluting to obtain a reference substance solution; respectively injecting the reference solution and the test solution into an ion chromatograph, recording chromatograms, and calculating by peak areas according to an external standard method to obtain the content of dimethylamine. According to the method for detecting the dimethylamine in the levofloxacin, the content of the dimethylamine in the levofloxacin is measured through the ion chromatography, the method is simple, convenient and feasible, high in specificity, high in accuracy and good in repeatability, the method has the advantages of being high in detection sensitivity, the content of the dimethylamine in the levofloxacin raw material can be accurately and sensitively detected, and the detection cost is low. Therefore, the quality of the levofloxacin raw material is ensured.

The invention provides a preparation method and application of a near-infrared response carbon dot composite bismuth vanadate / nickel oxide heterojunction photocatalyst. According to the material, levofloxacin is taken as a precursor, nitrogen-fluorine-doped carbon dots with an up-conversion characteristic are synthesized through a hydrothermal method, and the nitrogen-fluorine-doped carbon dots are compounded with a NiO nanosheet and a BiVO4 precursor which are prepared in advance by adopting a one-step hydrothermal strategy. Due to the up-conversion characteristic of the carbon dots, near-infrared light can be converted into visible light, spectral response is widened, and light capture efficiency is improved; meanwhile, the electron transmission capability of the material is cooperated with the built-in electric field of the BiVO4 / NiO p-n heterojunction, a multi-dimensional transmission channel is constructed, and carrier recombination is inhibited, so that the generation efficiency of active oxygen is remarkably improved, and the photocatalytic material with near-infrared light response characteristics, excellent antibiotic degradation performance and high stability is finally obtained.

This application relates to the field of drug synthesis technology and provides a method for preparing levofloxacin. The method includes first mixing N,N-dimethylaminoacrylate, triethylamine, and toluene, then adding 2,3,4,5-tetrafluorobenzoyl fluoride dropwise and reacting it with L-2-aminopropanol. After post-treatment, a toluene solution of the amine is obtained. Next, using N,N-dimethylformamide or toluene as a solvent, a cyclization reaction is carried out with differentiated feeding methods and temperature control. The product is purified by hot slurrying with a non-alcoholic organic solvent or a saturated alcohol solution of the levofloxacin cyclase. Finally, the product is purified by acidic hydrolysis, piperacillin reaction, and dimethyl sulfoxide to obtain high-purity levofloxacin. This application optimizes solvent selection and process integration, shortens reaction time, improves product yield and purity, reduces waste emissions, allows for resource utilization of byproducts, and features a simple and easily industrialized process suitable for large-scale production.